X

Health Care

Torrent Pharmaceuticals Ltd (TORNTPHARM) Q1 FY22 Earnings Concall Transcript

Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) Q1 FY22 Earnings Concall dated Jul. 29, 2022 Corporate Participants: Sudhir Menon -- Executive Director, Finance…

Cipla Limited (CIPLA) Q1 FY23 Earnings Concall Transcript

Cipla Limited (NSE:CIPLA) Q1 FY23 Earnings Concall dated Jul. 29, 2022 Corporate Participants: Naveen Bansal -- Head of Investor Relations…

Dr Reddy’s Laboratories Ltd. Q1FY23; 6% growth in Revenue

Revenue for Q1 FY23 has increased by 6% YoY to ₹ 52,154 millions. Profits have grown by 108% YoY to…

SBI LIFE INSURANCE CO LTD (SBILIFE) Q1 FY23 Earnings Concall Transcript

SBI LIFE INSURANCE CO LTD (NSE:SBILIFE) Q1 FY23 Earnings Concall dated Jul. 28, 2022 Corporate Participants: Mahesh Kumar Sharma -- Managing…

Dr Lal PathLabs Ltd (LALPATHLAB) Q1 FY23 Earnings Concall Transcript

Dr Lal PathLabs Ltd  (NSE:LALPATHLAB) Q1 FY23 Earnings Concall dated Jul. 28, 2022 Corporate Participants: Arvind Lal -- Executive Chairman…

Biocon Limited (BIOCON) Q1 FY23 Earnings Concall Transcript

Biocon Limited  (NSE : BIOCON) Q1 FY23 Earnings Concall dated July. 27, 2022 Corporate Participants: Kiran Mazumdar Shaw -- Executive Chairperson Biocon…

Syngene International Ltd Q1 FY23 Earnings Conference Call Insights

https://youtu.be/xL_nlERmIDQ Key highlights from Syngene International Ltd (SYNGENE) Q1 FY23 Earnings Concall Q&A Highlights: Prakash Agarwal from Axis Capital asked…

Gland Pharma Limited (GLAND) Q1 FY23 Earnings Concall Transcript

Gland Pharma Limited (NSE: GLAND) Q1 FY23 Earnings Concall dated Jul. 20, 2022 Corporate Participants: Sumanta Bajpayee -- Vice President, Corporate Finance…

Gland Pharma Limited Q1 FY23 Earnings Conference Call Insights

https://youtu.be/wKPiFWdsaFY Key highlights from Gland Pharma Limited (GLAND) Q1 FY23 Earnings Concall Management Update: GLAND said it is experiencing increased…

Gland Pharma Ltd. for Q1FY23 reports a 35% fall in Profits

Revenue has fell by 26% YoY to ₹8,569 millions. Core Market Revenue has decreased by 6% and Rest of the…